Skip to main content
Premium Trial:

Request an Annual Quote

IP Update: Recent Patents Awarded to Alnylam Pharmaceuticals, Marina Biotech, and More

Premium

Title: Methods and Means for Producing Efficient Silencing Construct Using Recombinatorial Cloning

Patent Number: 8,877,435

Filed: Sept. 21, 2010

Lead Inventor: Christopher Helliwell, Commonwealth Scientific and Industrial Research Organization


Title: Method for Rapidly Evaluating Performance of Short Interfering RNA with Novel Chemical Modifications

Patent Number: 8,877,439

Filed: Dec. 9, 2010

Lead Inventor: Gabor Butora, Sirna Therapeutics (Alnylam Pharmaceuticals)


Title: Compositions for Inhibiting Gene Expression and Uses Thereof

Patent Number: 8,877,722

Filed: March 25, 2011

Lead Inventor: Sudhir Agrawal, Idera Pharmaceuticals


Title: Method and Medicament for Inhibiting the Expression of a Given Gene

Patent Number: 8,877,726

Filed: Oct. 19, 2012

Lead Inventor: Roland Kreutzer, Alnylam Pharmaceuticals


Title: Delivery of dsRNA to Arthropods

Patent Number: 8,877,727

Filed: April 5, 2013

Lead Inventor: Steven Whyard, Commonwealth Scientific and Industrial Research Organization


Title: Amino Acid Lipids and Uses Thereof

Patent Number: 8,877,729

Filed: July 1, 2013

Lead Inventor: Steven Quay, Marina Biotech


Title: Glycoconjugates of RNA Interference Agents

Patent Number: 8,877,917

Filed: April 23, 2008

Lead Inventor: Andrea Forst, Alnylam Pharmaceuticals

The Scan

Study Reveals New Details About Genetics of Major Cause of Female Infertility

Researchers in Nature Medicine conducted a whole-exome sequencing study of mote than a thousand patients with premature ovarian insufficiency.

Circulating Tumor DNA Shows Potential as Biomarker in Rare Childhood Cancer

A study in the Journal of Clinical Oncology has found that circulating tumor DNA levels in rhabdomyosarcoma may serve as a biomarker for prognosis.

Study Recommends Cancer Screening for Dogs Beginning Age Seven, Depending on Breed

PetDx researchers report in PLOS One that annual cancer screening for dogs should begin by age seven.

White-Tailed Deer Harbor SARS-CoV-2 Variants No Longer Infecting Humans, Study Finds

A new study in PNAS has found that white-tailed deer could act as a reservoir of SARS-CoV-2 variants no longer found among humans.